Project snapshot: Development of a stable-side test for Hendra virus
Hendra virus (HeV) is a lethal pathogen of major concern to the equine industry in eastern Australia. Currently, conclusive diagnosis of HeV is only possible...
THOROUGHBRED HORSES
The Pharmacokinetics of Equine Medications
115 pages
Published: 20 Jan 2012
Share this content
-
Download report PDF
Download -
Purchase a hard copy - AUD $55.00
This RIRDC report provides information about the pharmacokinetics of 12 equine medications. For each medication, the report illustrates that time taken for the drug to reach its maximum concentration (and hence maximum effectiveness) in the blood, its rate of metabolism and removal from the bloodstream, and the time taken for the drug and its metabolites to be eliminated from the body via the urine.
The report also provides new insights into how metabolite data can be modelled to provide useful information about the behaviour of the parent drug, and how the variation between individual horses can be measured and used to estimate the level of risk of any horse in the population of breaching a detection limit at any given time point after drug administration.
This information should assist veterinarians to develop more effective treatment protocols for horses, and will assist the racing industry regulators in setting appropriate detection times and reporting levels for therapeutic substances in animals that compete.
Related resources
Managing the human risk of equine fetal loss
Prevent the spread of diseases between horses and humans through proactive protection. Equine fetal loss/abortions pose a risk to human health in the form of...
Industry blueprint: Thoroughbred Horses
This blueprint serves as a resource for those interested in the thoroughbred horse industry and provides essential fast facts alongside the fundamental themes highlighted in...
Project snapshot: Preparing the thoroughbred industry for operations during a possible foot and mouth disease outbreak
The re-emergence of foot and mouth disease (FMD) in Indonesia in 2022 has emphasised the need for Australia to be prepared for a potential incursion....
Preparing the thoroughbred industry for operations during a possible foot and mouth disease outbreak
In the wake of the 2022 foot and mouth disease (FMD) resurgence in Indonesia, there is a critical need for Australia to be prepared in...
Project snapshot: Bacteriophage and Rhodococcus equi pneumonia risk
The Australian thoroughbred breeding industry continues to grapple with managing risks related to Rhodococcus equi pneumonia, commonly known as ‘rattles’. The disease compromises foal health...
Project snapshot: Rapid diagnosis of strangles to improve horse health
Infectious diseases can cause significant equine illness and death, seriously impacting the productivity of the Australian thoroughbred breeding industry and incurring economic losses. One well-known...
Fit to foal: Managing the pregnant mare for maximum foal survival
The Australian thoroughbred breeding industry is second in size only to that of the United States, with 660 stud farms predominantly in New South Wales,...